Carmat SA
PAR:ALCAR

Watchlist Manager
Carmat SA Logo
Carmat SA
PAR:ALCAR
Watchlist
Price: 1.066 EUR -5.5% Market Closed
Market Cap: 45.2m EUR
Have any thoughts about
Carmat SA?
Write Note

Carmat SA
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Carmat SA
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Carmat SA
PAR:ALCAR
Cash & Cash Equivalents
€11.4m
CAGR 3-Years
-42%
CAGR 5-Years
-6%
CAGR 10-Years
4%
Edap Tms SA
NASDAQ:EDAP
Cash & Cash Equivalents
€43.5m
CAGR 3-Years
21%
CAGR 5-Years
17%
CAGR 10-Years
21%
Biomerieux SA
PAR:BIM
Cash & Cash Equivalents
€272.2m
CAGR 3-Years
-18%
CAGR 5-Years
2%
CAGR 10-Years
11%
Biosynex SA
PAR:ALBIO
Cash & Cash Equivalents
€5.4m
CAGR 3-Years
-62%
CAGR 5-Years
35%
CAGR 10-Years
18%
Visiomed Group SA
PAR:ALVMG
Cash & Cash Equivalents
€3m
CAGR 3-Years
54%
CAGR 5-Years
36%
CAGR 10-Years
11%
Amplitude Surgical SA
PAR:AMPLI
Cash & Cash Equivalents
€29.1m
CAGR 3-Years
-2%
CAGR 5-Years
8%
CAGR 10-Years
N/A
No Stocks Found

Carmat SA
Glance View

Market Cap
45.2m EUR
Industry
Health Care

Carmat SA engages in the developing of implantable orthotropic and biocompatible artificial heart. The company is headquartered in Velizy-Villacoublay, Ile-De-France and currently employs 160 full-time employees. The company went IPO on 2010-07-07. The firm is developing an orthotopic and biocompatible artificial heart which works like a natural heart and which is hydraulically activated. The firm formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels and Blood Institute, Laboratoire de Recherche Biochirurgicale and others. As of December 31, 2011, a company MATRA DEFENSE held a 30.57% stake in the Company’s shareholdings.

ALCAR Intrinsic Value
4.995 EUR
Undervaluation 79%
Intrinsic Value
Price

See Also

What is Carmat SA's Cash & Cash Equivalents?
Cash & Cash Equivalents
11.4m EUR

Based on the financial report for Jun 30, 2024, Carmat SA's Cash & Cash Equivalents amounts to 11.4m EUR.

What is Carmat SA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
4%

Over the last year, the Cash & Cash Equivalents growth was -52%. The average annual Cash & Cash Equivalents growth rates for Carmat SA have been -42% over the past three years , -6% over the past five years , and 4% over the past ten years .

Back to Top